Parathyroid Hormone-Related Protein for the Treatment of Postmenopausal Osteoporosis: Defining the Maximal Tolerable Dose-Reference-Cited by-同舟云学术

Parathyroid Hormone-Related Protein for the Treatment of Postmenopausal Osteoporosis: Defining the Maximal Tolerable Dose

Published:2010-03-01 Issue:3 Volume:95 Page:1279-1287
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Horwitz Mara J.¹,Tedesco Mary Beth¹,Garcia-Ocaña Adolfo¹,Sereika Susan M.²,Prebehala Linda¹,Bisello Alessandro³,Hollis Bruce W.⁴,Gundberg Caren M.⁵,Stewart Andrew F.¹

Affiliation:

1. Division of Endocrinology and Metabolism (M.J.H., M.B.T., A.G.-O., L.P., A.F.S.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213

2. The Graduate School of Public Health (S.M.S.), University of Pittsburgh, Pittsburgh Pennsylvania 15261

3. Department of Pharmacology and Chemical Biology (A.B.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213

4. Department of Pediatrics (B.W.H.), The Medical University of South Carolina, Charleston, South Carolina 29425

5. Department of Orthopedics (C.M.G.), Yale University School of Medicine, New Haven, Connecticut 06520

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/95/3/1279/9067473/jcem1279.pdf

Reference33 articles.

1. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis;Neer;N Engl J Med,2001

2. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis;Black;N Engl J Med,2003

3. The effects of parathyroid hormone, alendronate or both in men with osteoporosis;Finkelstein;N Engl J Med,2003

4. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis;Greenspan;Ann Int Med,2007

5. Randomized clinical trial of the effect of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women with osteoporosis;Lindsay;Lancet,1997

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commentary on “Quantitative Comparison of Vertebral Structural Changes After Percutaneous Vertebroplasty Between Unilateral Extrapedicular Approach and Bilateral Transpedicular Approach Using Voxel-Based Morphometry”;Neurospine;2023-12-31

2. Bone Remodeling and Modeling: Cellular Targets for Antiresorptive and Anabolic Treatments, Including Approaches Through the Parathyroid Hormone (PTH)/PTH-Related Protein Pathway;Neurospine;2023-12-31

3. Biologics: Teriparatide and Newer Anabolics;Indian Journal of Orthopaedics;2023-11-29

4. Abaloparatide prevents immobilization‐induced cortical but not trabecular bone loss after spinal cord injury;The FASEB Journal;2023-05-23

5. Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as PTH (1–34);JBMR Plus;2023-01-05